Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
High incidence of atrial fibrillation in patients treated with ibrutinib. [electronic resource] by
- Baptiste, Florian
- Cautela, Jennifer
- Ancedy, Yan
- Resseguier, Noémie
- Aurran, Thérèse
- Farnault, Laure
- Escudier, Marion
- Ammar, Chloé
- Gaubert, Mélanie
- Dolladille, Charles
- Barraud, Jeremie
- Peyrol, Michael
- Cohen, Ariel
- Paganelli, Franck
- Alexandre, Joachim
- Ederhy, Stephane
- Thuny, Franck
Publication details: Open heart
In:
Open heart vol. 6
Availability: No items available.
|
|
5.
|
Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma. [electronic resource] by
- Crocchiolo, Roberto
- Chabannon, Christian
- El-Cheikh, Jean
- Esterni, Benjamin
- Lemarié, Claude
- Fürst, Sabine
- Castagna, Luca
- Bouabdallah, Reda
- Ladaique, Patrick
- Coso, Diane
- Schiano, Jean Marc
- Stoppa, Anne Marie
- Rey, Jerome
- Ivanov, Vadim
- Aurran, Therese
- Faucher, Catherine
- Blaise, Didier
- Calmels, Boris
Producer: 20130617
In:
Leukemia & lymphoma vol. 54
Availability: No items available.
|
|
6.
|
A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone. [electronic resource] by
- Leblond, Véronique
- Morel, Pierre
- Dilhuidy, Marie-Sarah
- Leleu, Xavier
- Soussain, Carole
- Leprête, Stéphane
- Dreyfus, Brigitte
- Dartigeas, Caroline
- Mahé, Béatrice
- Anglaret, Bruno
- Pégourié, Brigitte
- Besson, Caroline
- Aurran, Thérèse
- Vekhoff, Anne
- Tournilhac, Olivier
- Banos, Anne
- Oya, Hervé
- Lejeune, Julie
- Ouzegdouh, Maya
- Chevret, Sylvie
Producer: 20180417
In:
Leukemia & lymphoma vol. 58
Availability: No items available.
|
|
7.
|
Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial. [electronic resource] by
- Lepretre, Stephane
- Aurran, Therese
- Mahé, Beatrice
- Cazin, Bruno
- Tournilhac, Olivier
- Maisonneuve, Herve
- Casasnovas, Olivier
- Delmer, Alain
- Leblond, Veronique
- Royer, Bruno
- Corront, Bernadette
- Chevret, Sylvie
- Delépine, Roselyne
- Vaudaux, Sandrine
- Van Den Neste, Eric
- Béné, Marie Christine
- Letestu, Remi
- Cymbalista, Florence
- Feugier, Pierre
Producer: 20120730
In:
Blood vol. 119
Availability: No items available.
|
|
8.
|
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study. [electronic resource] by
- Meunier, Godelieve
- Ysebaert, Loic
- Nguyen-Thi, Phi Linh
- Lepretre, Stéphane
- Quinquenel, Anne
- Dupuis, Jehan
- Lemal, Richard
- Aurran, Thérèse
- Tomowiak, Cécile
- Cymbalista, Florence
- Dilhuydy, Marie Sarah
- Brion, Annie
- Morel, Pierre
- Cazin, Bruno
- Leblond, Véronique
- Cartron, Guillaume
- Ré, Daniel
- Béné, Marie Christine
- Michallet, Anne Sophie
- Feugier, Pierre
Producer: 20180112
In:
Hematological oncology vol. 35
Availability: No items available.
|
|
9.
|
Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia. [electronic resource] by
- Feugier, Pierre
- Aurran, Thérèse
- Mahé, Béatrice
- Letestu, Remi
- Nguyen-Khac, Florence
- Cazin, Bruno
- Tournilhac, Olivier
- Maisonneuve, Hervé
- Casasnovas, Olivier
- Delmer, Alain
- Leblond, Véronique
- Royer, Bruno
- Corront, Bernadette
- Chevret, Sylvie
- Delépine, Roselyne
- Vaudaux, Sandrine
- Van Den Neste, Eric
- Béné, Marie-Christine
- Cymbalista, Florence
- Ross-Weil, Damien
- Leprêtre, Stéphane
Producer: 20190801
In:
Haematologica vol. 103
Availability: No items available.
|
|
10.
|
Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study. [electronic resource] by
- Cartron, Guillaume
- Letestu, Rémi
- Dartigeas, Caroline
- Tout, Mira
- Mahé, Béatrice
- Gagez, Anne-Laure
- Ferrant, Emmanuelle
- Guiu, Boris
- Villemagne, Bruno
- Letuan, Phan
- Aurran, Thérèse
- Orsini-Piocelle, Frédérique
- Banos, Anne
- Feugier, Pierre
- Leblond, Véronique
- de Guibert, Sophie
- Tournilhac, Olivier
- Dupuis, Jehan
- Delmer, Alain
- Rouillé, Valérie
- Ternant, David
- Leprêtre, Stéphane
Producer: 20191002
In:
Haematologica vol. 103
Availability: No items available.
|
|
11.
|
Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group. [electronic resource] by
- Quinquenel, Anne
- Godet, Sophie
- Dartigeas, Caroline
- Ysebaert, Loïc
- Dupuis, Jehan
- Ohanyan, Haykanush
- Collignon, Aude
- Gilardin, Laurent
- Lepretre, Stéphane
- Dilhuydy, Marie-Sarah
- Vignon, Marguerite
- de Guibert, Sophie
- Dmytruk, Natalia
- Durot, Eric
- Ghez, David
- Roos Weil, Damien
- Béné, Marie-Christine
- Toussaint, Elise
- Merabet, Fatiha
- Lévy, Vincent
- Delmer, Alain
- Aurran, Thérèse
Producer: 20200310
In:
American journal of hematology vol. 94
Availability: No items available.
|
|
12.
|
Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia. [electronic resource] by
- Dartigeas, Caroline
- Van Den Neste, Eric
- Berthou, Christian
- Maisonneuve, Hervé
- Leprêtre, Stéphane
- Dilhuydy, Marie-Sarah
- Béné, Marie-Christine
- Nguyen-Khac, Florence
- Letestu, Rémi
- Cymbalista, Florence
- De Guibert, Sophie
- Aurran, Thérèse
- Laribi, Kamel
- Vilque, Jean-Pierre
- Tournilhac, Olivier
- Delmer, Alain
- Feugier, Pierre
- Cazin, Bruno
- Michallet, Anne-Sophie
- Lévy, Vincent
- Troussard, Xavier
- Delepine, Roselyne
- Tavernier, Elsa
- Colombat, Philippe
- Leblond, Véronique
Publication details: Leukemia & lymphoma Feb 2016
In:
Leukemia & lymphoma vol. 57
Availability: No items available.
|
|
13.
|
Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial. [electronic resource] by
- Michallet, Anne-Sophie
- Dilhuydy, Marie-Sarah
- Subtil, Fabien
- Rouille, Valerie
- Mahe, Beatrice
- Laribi, Kamel
- Villemagne, Bruno
- Salles, Gilles
- Tournilhac, Olivier
- Delmer, Alain
- Portois, Christelle
- Pegourie, Brigitte
- Leblond, Veronique
- Tomowiak, Cecile
- de Guibert, Sophie
- Orsini, Frederique
- Banos, Anne
- Carassou, Philippe
- Cartron, Guillaume
- Fornecker, Luc Mathieu
- Ysebaert, Loic
- Dartigeas, Caroline
- Truchan Graczyk, Malgorzata
- Vilque, Jean P
- Aurran, Thérèse
- Cymbalista, Florence
- Lepretre, Stéphane
- Lévy, Vincent
- Nguyen-Khac, Florence
- Le Garff-Tavernier, Magali
- Aanei, Carmen
- Ticchioni, Michel
- Letestu, Rémi
- Feugier, Pierre
Producer: 20191030
In:
The Lancet. Haematology vol. 6
Availability: No items available.
|